David M. Stern
#126,607
Most Influential Person Now
David M. Stern's AcademicInfluence.com Rankings
David M. Sternbiology Degrees
Biology
#8058
World Rank
#11074
Historical Rank
Physiology
#219
World Rank
#416
Historical Rank
Download Badge
Biology
Why Is David M. Stern Influential?
(Suggest an Edit or Addition)David M. Stern's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endothelial cells in physiology and in the pathophysiology of vascular disorders. (1998) (2454)
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease (1996) (1824)
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor (1986) (1307)
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain (2003) (1274)
- Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases (2000) (1259)
- ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease (2004) (1234)
- Understanding RAGE, the receptor for advanced glycation end products (2005) (1183)
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. (2001) (1168)
- Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts (1998) (1127)
- Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. (2001) (981)
- Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. (2001) (832)
- Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. (2004) (748)
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology (1994) (730)
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration (1990) (711)
- The biology of the receptor for advanced glycation end products and its ligands. (2000) (696)
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 (1986) (675)
- Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease (2005) (619)
- Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. (1986) (593)
- RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. (2003) (586)
- RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice (2002) (571)
- Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. (1994) (540)
- Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses (2002) (538)
- Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. (1996) (538)
- Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. (2001) (532)
- The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. (2005) (532)
- Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. (2004) (525)
- Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress (2000) (468)
- Role of NFkappaB in the mortality of sepsis. (1997) (449)
- Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. (1994) (437)
- Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. (2000) (436)
- Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. (2001) (426)
- Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism (2001) (416)
- Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide (1995) (414)
- Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (2012) (410)
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins (1989) (401)
- Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. (2005) (388)
- Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties (1989) (386)
- An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease (1997) (381)
- RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response (2002) (375)
- Central role of RAGE-dependent neointimal expansion in arterial restenosis. (2003) (370)
- Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. (1990) (360)
- Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6 (1995) (358)
- Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. (2000) (334)
- Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis (2000) (332)
- Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. (1990) (331)
- RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice (2004) (312)
- Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals (1995) (304)
- RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease (2002) (303)
- Complement-mediated regulation of tissue factor activity in endothelium (1995) (298)
- Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. (2004) (292)
- Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. (1996) (287)
- Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. (1986) (286)
- Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice (2001) (279)
- RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease (2010) (273)
- RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction (2009) (271)
- Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes (2002) (267)
- Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* (1999) (259)
- ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction (2005) (247)
- Self-regulation of procoagulant events on the endothelial cell surface (1985) (233)
- Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. (1996) (230)
- Circulating CD34-Positive Cells Provide an Index of Cerebrovascular Function (2004) (206)
- Role of the JAK/STAT signaling pathway in diabetic nephropathy. (2006) (205)
- An endothelial cell-dependent pathway of coagulation. (1985) (204)
- Interleukin 1 is an autocrine regulator of human endothelial cell growth. (1990) (197)
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction (2008) (196)
- Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system (2003) (196)
- ORP150 protects against hypoxia/ischemia-induced neuronal death (2001) (195)
- Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. (1998) (193)
- Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. (1992) (187)
- Purification and Characterization of a Novel Stress Protein, the 150-kDa Oxygen-regulated Protein (ORP150), from Cultured Rat Astrocytes and Its Expression in Ischemic Mouse Brain (*) (1996) (186)
- The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. (1994) (186)
- Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. (1993) (186)
- Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival (1994) (184)
- RAGE in inflammation: a new therapeutic target? (2006) (175)
- Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. (2003) (174)
- RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes (2000) (172)
- Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury (2003) (171)
- Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. (1999) (171)
- Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. (2001) (170)
- Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes (2002) (167)
- Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. (2001) (166)
- 150-kDa Oxygen-regulated Protein (ORP150) Suppresses Hypoxia-induced Apoptotic Cell Death* (1999) (165)
- Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas (1988) (164)
- Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S (1986) (163)
- Hypoxia induces glucose transporter expression in endothelial cells. (1992) (163)
- The dark side of glucose (1995) (161)
- Regulation of osteoclast function and bone mass by RAGE (2006) (158)
- RAGE‐mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs) (2002) (157)
- Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. (1997) (156)
- Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. (1996) (155)
- Inhibition of Amyloid-β (Aβ) Peptide-Binding Alcohol Dehydrogenase-Aβ Interaction Reduces Aβ Accumulation and Improves Mitochondrial Function in a Mouse Model of Alzheimer's Disease (2011) (154)
- Endothelial Cells Support Survival, Proliferation, and Neuronal Differentiation of Transplanted Adult Ischemia‐Induced Neural Stem/Progenitor Cells After Cerebral Infarction (2009) (152)
- Early Growth Response-1 Promotes Atherogenesis: Mice Deficient in Early Growth Response-1 and Apolipoprotein E Display Decreased Atherosclerosis and Vascular Inflammation (2004) (138)
- RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? (2009) (137)
- RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. (2000) (133)
- Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products1 (2004) (130)
- Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. (2001) (130)
- Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. (1989) (129)
- Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. (2005) (128)
- Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. (2005) (123)
- Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells (1999) (123)
- Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* (1999) (122)
- Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. (2006) (121)
- Stress-Associated Endoplasmic Reticulum Protein 1 (Serp1)/Ribosome-Associated Membrane Protein 4 (Ramp4) Stabilizes Membrane Proteins during Stress and Facilitates Subsequent Glycosylation (1999) (119)
- Binding of factors IX and IXa to cultured vascular endothelial cells. (1983) (117)
- TNF modulates endothelial properties by decreasing cAMP. (1995) (116)
- Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD) (2005) (116)
- Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor (*) (1995) (116)
- Role of Herp in the endoplasmic reticulum stress response (2004) (112)
- Role of NF k B in the Mortality of Sepsis (1997) (112)
- Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. (2007) (112)
- Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. (2001) (110)
- Activation of coagulation releases endothelial cell mitogens (1986) (110)
- Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. (2000) (103)
- Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity. (1985) (103)
- Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. (1995) (101)
- Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va. (1986) (101)
- Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. (2005) (100)
- Extracellular High-Mobility Group Box 1 Acts as an Innate Immune Mediator to Enhance Autoimmune Progression and Diabetes Onset in NOD Mice (2008) (99)
- Exposure of Astrocytes to Hypoxia/Reoxygenation Enhances Expression of Glucose‐Regulated Protein 78 Facilitating Astrocyte Release of the Neuroprotective Cytokine Interleukin 6 (1996) (95)
- Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. (1991) (95)
- Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model. (1991) (94)
- Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. (2002) (93)
- Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. (1993) (93)
- Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). (2000) (93)
- Advanced Glycation End Product Receptor‐Mediated Cellular Dysfunction (2005) (92)
- Macrovascular and microvascular endothelium during long‐term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties (1991) (91)
- Mitochondrial dysfunction and Alzheimer's disease. (2006) (90)
- Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients (2015) (87)
- A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin. (1984) (87)
- Posttranslationally modified proteins as mediators of sustained intestinal inflammation. (2006) (84)
- Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. (1998) (84)
- 150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein. (1996) (83)
- Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. (2001) (81)
- ORP150/HSP12A protects renal tubular epithelium from ischemia‐induced cell death (2004) (79)
- Hypoxia-induced modulation of endothelial cell properties: regulation of barrier function and expression of interleukin-6. (1997) (79)
- Calreticulin, an Antithrombotic Agent Which Binds to Vitamin K-dependent Coagulation Factors, Stimulates Endothelial Nitric Oxide Production, and Limits Thrombosis in Canine Coronary Arteries (*) (1995) (78)
- S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. (2003) (77)
- Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. (1995) (76)
- Endothelium and Regulation of Coagulation (1991) (73)
- The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function (1990) (71)
- ORP150/HSP12A Regulates Purkinje Cell Survival: A Role for Endoplasmic Reticulum Stress in Cerebellar Development (2004) (69)
- A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. (1990) (68)
- Glycation and diabetes: The RAGE connection (2002) (67)
- Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface (1992) (65)
- Prostacyclin production by perturbed bovine aortic endothelial cells in culture. (1984) (65)
- Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin [published erratum appears in J Exp Med 1989 Nov 1;170(5):1793] (1989) (65)
- RAGE-AB Interactions in the Pathophysiology of Alzheimer's Disease (1998) (64)
- Metabolic and Biosynthetic Alterations in Cultured Astrocytes Exposed to Hypoxia/Reoxygenation (1994) (64)
- Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides. (1989) (63)
- Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma. (1996) (63)
- Extinguishing Egr‐1‐dependent inflammatory and thrombotic cascades following lung transplantation (2001) (62)
- Increase in Circulating CD34-Positive Cells in Patients with Angiographic Evidence of Moyamoya-like Vessels (2008) (62)
- Deletion of SERP1/RAMP4, a Component of the Endoplasmic Reticulum (ER) Translocation Sites, Leads to ER Stress (2006) (61)
- Series introduction: multiligand receptors and human disease. (2001) (60)
- Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. (2006) (60)
- Expression of the 150-kd oxygen-regulated protein in human breast cancer. (1998) (59)
- Tissue factor as a link between wounding and tissue repair. (2005) (58)
- Regulation of the coagulation system by vascular endothelial cells. (1988) (58)
- Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. (1995) (58)
- Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. (2000) (57)
- Egr-1: is it always immediate and early? (2000) (56)
- A Reproducible and Simple Model of Permanent Cerebral Ischemia in CB-17 and SCID Mice. (2010) (56)
- Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. (1985) (56)
- The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X. (1985) (55)
- Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa. (1991) (54)
- Modulation of endothelial hemostatic properties: an active role in the host response. (1990) (52)
- PKCβ regulates ischemia/reperfusion injury in the lung (2004) (52)
- Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. (1992) (51)
- Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia (2010) (51)
- Activation of factor IX bound to cultured bovine aortic endothelial cells. (1984) (50)
- Human endothelium: endovascular biopsy and molecular analysis. (1999) (50)
- Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. (1995) (50)
- Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. (2000) (49)
- RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. (1998) (49)
- Expression of Egr-1 in late stage emphysema. (2000) (49)
- Hypoxia induces endothelial cell synthesis of membrane-associated proteins. (1991) (49)
- Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. (2002) (48)
- Colonoscopy in Mice (2001) (47)
- Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. (1999) (44)
- A pathway of coagulation on endothelial cells (1985) (44)
- In vivo evidence of intravascular binding sites for coagulation factor IX (1987) (43)
- The role of endothelium in the homeostatic balance of haemostasis. (1985) (42)
- Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo. (1999) (42)
- Circulating CD34-Positive Cells Have Prognostic Value for Neurologic Function in Patients with past Cerebral Infarction (2009) (42)
- Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog. (1998) (41)
- Acquired antibody to factor XI in a patient with congenital factor XI deficiency. (1982) (41)
- PKCbeta regulates ischemia/reperfusion injury in the lung. (2004) (41)
- Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. (1998) (41)
- Endothelial cell procoagulant properties and the host response. (1987) (41)
- CD166/ALCAM Mediates Proinflammatory Effects of S100B in Delayed Type Hypersensitivity (2013) (40)
- Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection (2009) (39)
- Modulation of endothelial function by hypoxia: perturbation of barrier and anticoagulant function, and induction of a novel factor X activator. (1990) (38)
- Visualization of intracerebral arteries by synchrotron radiation microangiography. (2007) (37)
- Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model (2012) (37)
- Atherosclerosis and restenosis: Is there a role for rage? (2005) (36)
- Interaction of Baboon Anti-α-Galactosyl Antibody with Pig Tissues (1999) (36)
- The multiple levels of endothelial cell-coagulation factor interactions. (1986) (35)
- Receptors for advanced glycation end-products (AGE)—expression by endothelial cells in non-diabetic uraemic patients (1996) (35)
- Hyperglycemia and reactive oxygen species mediate apoptosis in aortic endothelial cells through Janus kinase 2. (2005) (35)
- Angiotensin II–Induced Insulin Resistance and Protein Tyrosine Phosphatases (2004) (34)
- Hyperinsulinemia and vascular dysfunction: the role of nuclear factor-kappaB, yet again. (2000) (33)
- Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. (1995) (33)
- A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor. (1996) (32)
- Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. (1993) (31)
- Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation. (2001) (31)
- Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. (2009) (31)
- Cellular processing of bovine factors X and Xa by cultured bovine aortic endothelial cells (1985) (30)
- Identification of a factor IX/IXa binding protein on the endothelial cell surface. (1987) (30)
- Interleukin‐l Inhibits the Synthesis of von Willebrand Factor in Endothelial Cells, Which Results in a Decreased Reactivity of Their Matrix toward Platelets (1987) (29)
- Receptors for advance glycation end-products (AGE) - expression by endothelial cells in non-diabetic uraemic patients. (1996) (27)
- B-RAGE – Mediated Augmentation of Angiotensin II – Induced Activation of JAK 2 in Vascular Smooth Muscle Cells Is Dependent on PLD 2 (2003) (27)
- Norepinephrine down-regulates the activity of protein S on endothelial cells (1988) (27)
- Endothelium and regulation of coagulation. (1991) (27)
- Circulating CD34-Positive Cells Provide a Marker of Vascular Risk Associated with Cognitive Impairment (2008) (26)
- Active site-blocked factor Xa prevents thrombus formation in the coronary vasculature in parallel with inhibition of extravascular coagulation in a canine thrombosis model. (1993) (24)
- Selective induction of endothelial cell tissue factor in the presence of a tumour‐derived mediator: A potential mechanism of flavone acetic acid action in tumour vasculature (1991) (24)
- Reduced ischemic brain injury by partial rejuvenation of bone marrow cells in aged rats (2010) (24)
- von Willebrand factor as a regulator of intrinsic factor X activation. (1994) (23)
- Cellular mechanisms of adaptation of grafts to antibody. (1996) (23)
- Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model. (2016) (23)
- Angiotensin II-induced signaling pathways in diabetes. (2005) (22)
- Cloning of a Putative Vesicle Transport-related Protein, RA410, from Cultured Rat Astrocytes and Its Expression in Ischemic Rat Brain* (1997) (22)
- Novel Preservation Solution Permits 24‐Hour Preservation in Rat and Baboon Cardiac Transplant Models (1993) (21)
- A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. (2006) (21)
- A radical approach to the pathogenesis of diabetic complications. (2000) (21)
- Mitochondrial amyloid-beta peptide: pathogenesis or late-phase development? (2006) (20)
- Key signaling pathways regulate the biological activities and accumulation of amyloid-β (2001) (20)
- Cellular Receptors for Advanced Glycation Endproducts (2005) (20)
- Selective Anticoagulation With Active Site Blocked Factor IXa in Synthetic Patch Vascular Repair Results in Decreased Blood Loss and Operative Time (1997) (20)
- Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures. (2002) (20)
- Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response. (1993) (19)
- Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. (2012) (17)
- Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumour necrosis factor. (1991) (16)
- alpha-galactosyl epitopes on glycoproteins of porcine renal extracellular matrix. (2000) (16)
- Anticoagulant and antithrombotic properties of a gamma-carboxyglutamic acid-rich peptide derived from the light chain of blood coagulation factor X. (1986) (16)
- Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties. (1987) (15)
- A pathway leading to hypoxia-induced vascular fibrin deposition. (2000) (15)
- Corrigendum: Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (2012) (14)
- A highly reproducible model of cerebral ischemia/reperfusion with extended survival in CB-17 mice (2013) (13)
- ENDOTHELIAL RECEPTOR-MEDIATED BINDING OF (1989) (13)
- Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium. (1993) (13)
- Chemokines on the rise : mcp-1 and restenosis. (2001) (13)
- Selective reduction of PVR by inhalation of a cGMP analogue in a porcine model of pulmonary hypertension. (1995) (12)
- Soluble forms of RAGE: an index of vascular stress? A commentary on "Soluble RAGE in type 2 diabetes: association with oxidative stress". (2007) (11)
- Alzheimer's disease: inside, outside, upside down. (2001) (11)
- Functional Interactions ofT Cells with Endothelial Cells : The Role of CD 40 LCD 40-mediated Signals (2003) (10)
- Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. (2000) (10)
- Implication of thrombin formation on the endothelial cell surface. (1986) (9)
- Membranous glomerulonephritis induced in the pig by antibody to angiotensin-converting enzyme: considerations on its relevance to the pathogenesis of human idiopathic membranous glomerulonephritis. (1999) (8)
- A rat model of human FENIB (familial encephalopathy with neuroserpin inclusion bodies). (2006) (8)
- Multiligand receptors and human disease (2001) (8)
- Cytokine-mediated control of endothelial cell growth: interferon-* and interleukin-2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting cell growth in vitro and in vivo. (1993) (7)
- Interaction of baboon anti-alpha-galactosyl antibody with pig tissues. (1999) (7)
- C. elegans as model for the study of high glucose mediated lifespan reduction Running title: Glucose regulates lifespan in C. elegans (2009) (7)
- α-Galactosyl antibody redistributes α-galactosyl at the surface of pig blood and endothelial cells (1999) (6)
- Endothelial precursor cells and CRP on the RAGE: activation or cell death? (2009) (6)
- The coagulation factor lottery – Is 9 the winning number?: An essay on future oral anticoagulants (2005) (5)
- Tumour-derived factors which induce endothelial tissue factor and enhance the procoagulant response to TNF. (1991) (5)
- Thromboxane production by perturbed bovine aortic endothelial cells in culture (2004) (4)
- 150-kDa Oxygen-regulated Protein ( ORP 150 ) Suppresses Hypoxia-induced Apoptotic Cell (1999) (4)
- RAGE: A Receptor with a Taste for Multiple Ligands and Varied Pathophysiologic States (1998) (4)
- Hypoxia-mediated modulation of vascular function--implications for organ preservation and thrombogenesis: Roger S. Mitchell lecture. (1998) (4)
- Endothelium is a target tissue for tumor necrosis factor (1986) (3)
- A pathway of coagulation on bovine capillary endothelial cells (1986) (3)
- The marriage of glucose and blood vessels: it isn't all that sweet. (2005) (3)
- Diabetes and cardiovascular disease : integrated science and clinical medicine (2004) (2)
- Alpha-galactosyl antibody redistributes alpha-galactosyl at the surface of pig blood and endothelial cells. (1999) (2)
- Erratum: Advanced maillard reaction end products are associated with Alzheimer disease pathology (Proceedings of the National Academy of Sciences of the United States of America (June 7, 1994) 91 (5710-5714) (1995) (2)
- Erratum: Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress (Nature Medicine (2000) 6 (13551-1361)) (2001) (1)
- Extracellular HMGB1 acts as an innate immune-mediator to enhance autoimmune progression and diabetes onset in NOD mice (2008) (1)
- Calreticulin and Thrombosis (1996) (1)
- Endothelial Cell Regulation of Coagulation (1998) (1)
- A New Protocol for Quantifying CD34 + Cells (2006) (1)
- Protective effects of complement blockade in an isograft model of lung preservation and transplantation (1996) (1)
- Modulation of Endothelial Coagulant Properties and Barrier Function by Factors in the Vascular Microenvironment (1992) (1)
- Method for treatment of wound healing in diabetics (1997) (0)
- Emerging therapeutic targets in diabetic vascular disease (1999) (0)
- [The endothelium as the central control site of the coagulation cascade]. (1989) (0)
- Treating ischemic disorder and improvement of the infarct-profit (1997) (0)
- 468. Tissue Factor as a Link Between Wounding and Tissue Repair (2004) (0)
- Modulation of Endothelial Cell Function by Hypoxia: Perturbation of Barrier and Anticoagulant Function, and Induction of a Novel Procoagulant Activity (1990) (0)
- Interaction of vitamin-K-dependent coagulation factors and the endothelium (1989) (0)
- Nitric Oxide and Tissue Preservation in Transplantation (2000) (0)
- Tumor Necrosis Factor/Cachectin and the Modulation of Endothelial Cell Coagulant Properties (1987) (0)
- surface with subendothelial matrix vesicles but is not expressed on the apical Tumor necrosis factor-induced endothelial tissue factor is associated (2003) (0)
- REGULATION OF GROWTH FACTOR PRODUCTION BY ENDOTHELIAL CELLS IN RESPONSE TO COAGULATION AND INFLAMATORY FACTORS (1987) (0)
- P4-227: Role of receptor for advanced glycation endproducts in neuronal amyloid β-peptide membrane transport (2008) (0)
- Using soluble receptors for advanced glycation end products (sRAGE) to prevent accelerated atherosclerosis. (1998) (0)
- VON WILLEBRAND FACTOR AS A REGULATOR OF ENDOTHELIAL CELL-DEPENDENT FACTOR Xa FORMATION (1987) (0)
- Contents, Vol. 18, 1988 (1988) (0)
- oxygen concentration Pulmonary expression of early growth response-1 : biphasic (2000) (0)
- Accelerated Vascular Changes of Nonproliferative Diabetic Retinopathy in a Murine Model of Diabetes (2003) (0)
- Subject Index, Vol. 18, 1988 (1988) (0)
- Correction (1973) (0)
- Infusion of soluble RAGE inhibits Abeta amyloid deposition in APP transgenic mice (2001) (0)
- Modulation of Endothelial Functions by Advanced Glycosylation End Products (1990) (0)
- Erratum: Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding (The Journal of Biological Chemistry, Vol. 264 (1989) 20283-20287) (1990) (0)
- Treatment of an ischemical disorder and improvement of the consequences of a cerebrovascular accident. (1997) (0)
- Malignant disease and pregnancy. (1968) (0)
- Modulation of Endothelial Barrier and Coagulant Properties by Hypoxia (1991) (0)
- Advanced Glycosylation End Products: Interactions with Cells (1991) (0)
- The nuclear factor-interleukin 6 motif mediates hypoxia-inducible gene expression Studies in transgenic mice (1995) (0)
- New extracellular binding protein rage (en-RAGE) and its uses. (1999) (0)
- Chronic neuronal perturbation mediated by RAGE, a receptor for β-sheet fibrils and S100/calgranulins (2001) (0)
- Cytokine Induced Stimulation of Endothelial Cells in Vitro (1990) (0)
- 2.W14.4 Tissue factor — role in coagulation and angiogenesis (1997) (0)
- ROLE OF PLATELET-ACTIVATING FACTOR IN FUNCTIONAL ALTERATIONS INDUCED BY XENOREACTIVE ANTIBODIES IN PORCINE ENDOTHELIAL CELLS1 (2000) (0)
- Hypoxia and Endothelial Cell Function: Alterations in Barrier and Coagulant Properties (1991) (0)
- ENDOTHELIUM AND PROTEIN S: SYNTHESIS, RELEASE AND REGULATION OF ANTICOAGULANT ACTIVITY (1987) (0)
- A novel gene therapy approach to tissue specific cytotoxicity in thyroid cells (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David M. Stern?
David M. Stern is affiliated with the following schools:
